Individual Differences of Multipotent Mesenchymal Stromal Cells Manifesting in during Interaction with Lymphocytes


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Analysis of changes in lymphocyte subpopulations during co-culturing with multipotent mesenchymal stromal cells (MSC) revealed two distinct MSC groups: one group (A) increased HLA-DR expression on lymphocytes during co-culturing and the other (B) did not change it in comparison with lymphocyte monoculture. In stromal cells interacting with lymphocytes, expression of HLA-DR molecules was initiated, but only in samples that induced enhanced expression on lymphocytes and irrespectively of whether allogeneic or autologous lymphocytes were used for co-culturing with MSC. In group A, the relative expression of IDO1 significantly increased in comparison with group B. The revealed individual differences in MSC can explain why not all MSC samples are effective in the treatment of autoimmune diseases, acute “graft—versus—host” disease, and other pathologies.

Sobre autores

N. Kapranov

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Rússia, Moscow

Yu. Davydova

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Rússia, Moscow

I. Gal’tseva

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Rússia, Moscow

N. Petinati

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Rússia, Moscow

N. Sats

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Rússia, Moscow

N. Drize

National Research Center for Hematology, Ministry of Health of the Russian Federation

Autor responsável pela correspondência
Email: ndrize@yandex.ru
Rússia, Moscow

L. Kuz’mina

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Rússia, Moscow

E. Parovichnikova

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Rússia, Moscow

V. Savchenko

National Research Center for Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Rússia, Moscow


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies